World Health Organisation, WHO on Monday said that it had “temporarily” suspended clinical trials of hydroxychloroquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure.
This was made known by WHO Director-General, Tedros Adhanom Ghebreyesus during a press conference on Monday.
He said, “The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board.”
READ ALSO:
https://ekohotblog.com/2020/05/25/sanwo-olu-to-mark-one-year-in-office-with-virtual-inauguration-of-projects/
The other arms of the trial are continuing,” Tedros said. “This concern relates to the use of hydroxychloroquine and chloraquine in Covid-19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria.”
He said the decision came after the publication last week of a study in the Lancet indicating that the use of the drug on COVID-19 patients could increase their likelihood of dying.
Discover more from EkoHotBlog
Subscribe to get the latest posts to your email.
Advertise or Publish a Story on EkoHot Blog:
Kindly contact us at [email protected]. Breaking stories should be sent to the above email and substantiated with pictorial evidence.
Citizen journalists will receive a token as data incentive.
Call or Whatsapp: 0803 561 7233, 0703 414 5611